UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000045942
Receipt No. R000052439
Scientific Title A Multicenter Observational Study on the Incidence of Infectious Endophthalmitis, Changes in Pathogenesis, and Visual Prognosis in Covid-19 pandemic period
Date of disclosure of the study information 2021/11/02
Last modified on 2021/12/14 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Multicenter Observational Study on the Incidence of Infectious Endophthalmitis, Changes in Pathogenesis, and Visual Prognosis in COVID-19 pandemic period
Acronym Investigation of the incidence of endophthalmitis in the COVID-19 pandemic period
Scientific Title A Multicenter Observational Study on the Incidence of Infectious Endophthalmitis, Changes in Pathogenesis, and Visual Prognosis in Covid-19 pandemic period
Scientific Title:Acronym Investigation of the incidence of endophthalmitis in the COVID-19 pandemic period
Region
Japan

Condition
Condition Endophthalmitis
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effects of wearing masks and refraining from hospital visits on the incidence, causative organisms, and prognosis of endophthalmitis, and to analyze factors that affect treatment outcomes and visual prognosis.
Basic objectives2 Others
Basic objectives -Others Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Incidence of endophthalmitis before and after COVID-19 pandemic period.
Key secondary outcomes Background of patients with endophthalmitis before and after COVID-19 period and its comparison, Examination of patient background that influences the pathogenesis of endophthalmitis before and after COVID-19 period, Examination of factors that influence visual prognosis.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients diagnosed with endophthalmitis and treated for endophthalmitis at the Department of Ophthalmology, Kagoshima University Hospital, and other facilities participating in the study between January 1, 2019, and June 30, 2021
Key exclusion criteria not applicable
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Taiji
Middle name
Last name Sakamoto
Organization Kagoshima University Graduate School of Medical and Dental Sciences
Division name Department of Ophthalmology
Zip code 890-8520
Address 8-35-1 Sakuragaoka, Kagoshima-shi, Kagoshima, Japan
TEL 099-275-5402
Email tsakamot@m3.kufm.kagoshima-u.ac.jp

Public contact
Name of contact person
1st name Taiji
Middle name
Last name Sakamoto
Organization Kagoshima University Graduate School of Medical and Dental Sciences
Division name Department of Ophthalmology
Zip code 890-8520
Address 8-35-1 Sakuragaoka, Kagoshima-shi, Kagoshima, Japan
TEL 099-275-5402
Homepage URL
Email tsakamot@m3.kufm.kagoshima-u.ac.jp

Sponsor
Institute Kagoshima University Graduate School of Medical and Dental Sciences
Institute
Department

Funding Source
Organization Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor J
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kagoshima University Hospital
Address 8-35-1 Sakuragaoka, Kagoshima-shi, Kagoshima, Japan
Tel 099-275-5111
Email isgskkrs@kuas.kagoshima-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions Japan Clinical Retina Study (J-CREST) group, Japan Reina and Vitreous Society (JRVS)

Other administrative information
Date of disclosure of the study information
2021 Year 11 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 08 Month 23 Day
Date of IRB
2021 Year 08 Month 23 Day
Anticipated trial start date
2021 Year 08 Month 23 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Retrospective observational study

Management information
Registered date
2021 Year 11 Month 01 Day
Last modified on
2021 Year 12 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052439